-
Mashup Score: 6Brexu-Cel Demonstrates Efficacy, Safety in Older Patients with R/R Mantle Cell Lymphoma - 4 day(s) ago
Brexu-cel demonstrated clinical activity and safety in patients over 70 years of age with relapsed/refractory mantle cell lymphoma.
Source: www.onclive.comCategories: General Medicine NewsTweet
Findings from a retrospective study showed that brexu-cel could represent a potential treatment option for patients over 70 years of age with R/R #MCL who do not benefit from intensive treatment. @TheEBMT #EBMT2025 https://t.co/mWW4rjrRR5